Journal of Cancer Metastasis and Treatment
About the journal
The journal concerns cancer metastasis and treatment, including the occurrence, development, progression, metastasis, and treatment of neoplastic diseases. Its coverage includes basic, translational and clinical studies related to cancer cell biology, genomics, precision medicine, medical oncology, radiation therapy and radiology, obstetrics and gynecology, pediatrics, surgery, hematology, neuro-oncology, etc. Articles in the following areas are especially welcome:Basic research on cancer occurrence and progression, focusing on molecular biology, cell biology, and genetics;Mechanisms of metastasis and its prevention and control;Basic and clinical research on treatment of primary, metastatic tumors and the like;Improved methods for medical, radiological, and/or surgical treatment of metastatic tumors (immunotherapy, chemotherapy, radiotherapy, biological therapy, operative treatment, interventional therapy, etc.);Observational/epidemiological studies focusing on environmental and behavioral factors that reduce the risk of cancer progression and metastasis and gene/environment interactions;Primary and secondary prevention studies.JCMT publishes high-quality original articles, reviews, case reports, commentaries, letters to editor, etc.
Search Journal of Cancer Metastasis and Treatment
The predictive role of hematologic indicators in locally advanced esophageal squamous cell carcinoma patients receiving neoadjuvant chemoimmunotherapy
Chronic inflammation and immune response in hepatocellular carcinoma: a comprehensive literature review
Functional significance of miR-218 in lung cancer
Circulating tumor DNA (ctDNA) in early-stage NSCLC: a new frontier in precision oncology
Censor-aware semi-supervised survival time prediction in lung cancer using clinical and radiomics features
Interconnections within the tumor microenvironment: extracellular vesicles as cr...
The role of miRNAs in the extracellular vesicle-mediated interplay between breas...
Factors associated with prognosis and staging of intrahepatic cholangiocarcinoma
Research advances in immunotherapy combined with DNA damage response inhibitors ...
Non-coding RNAs and Beyond: Cancer Metastasis Mechanisms and Precision Therapy
Submission Deadline: 30 Apr 2027 Published articles: 0
Proceedings of Congresses on Cancer Sciences
Submission Deadline: 31 Dec 2026 Published articles: 0





























